Novel OCT prognostic indicators in diabetic macular oedema

Publisher： John Wiley & Sons Inc

E-ISSN： 1755-3768|94|S256|j.1755-3768.2016.0530-j.1755-3768.2016.0530

ISSN： 1755-375X

Source： ACTA OPHTHALMOLOGICA, Vol.94, Iss.S256, 2016-10, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diabetic macular oedema: evidence‐based treatment recommendations for Asian countries

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 46, Iss. 1, 2018-01 ,pp. : 75-86

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of retinal layer thickness in diabetic macular oedema treated with ranibizumab or triamcinolone

By  

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. 2, 2018-03 ,pp. : e195-e200

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of SD‐OCT prognostic factors in macular edema associated with retinal vein occlusion

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Iluvien monotherapy for diabetic macular oedema in vitrectomised and non‐vitrectomised eyes: one year data

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Influence of serum lipids on the incidence and progression of diabetic retinopathy and macular oedema: Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular genetics Study‐II

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 45, Iss. 9, 2017-12 ,pp. : 894-900

John Wiley & Sons Inc

Access to resources Recommend Favorite